Trucks might outsell cars in 2000

Article Abstract:

Bestfoods, based in Englewood Cliffs, NJ, on May 2, 2000 rejected Unilever PLC's unsolicited $18-billion takeover proposal because the offer was 'financially inadequate.' With the unsuccessful bid, Bestfoods' shares are predicted to soar and hostile takeover is expected from leading other branded food suppliers, such as Campbell Soup Co, H.J. Heinz Co and Procter & Gamble Co. Bestfoods is the maker of Skippy peanut butter and Hellmann's mayonnaise with $8.6-billion revenue annually.

Sales & consumption, Light Truck and Utility Vehicle Manufacturing, Trucks, Light Duty, Unilever Group, Bestfoods, Light duty trucks

---

Mega-merger promises bounty of new products

Article Abstract:

The proposed $34.6 billion merger of Madison, NJ-based American Home Products and Monsanto of St. Louis, MO, will create a powerhouse in the life sciences industry. The new company will have the ability to use genetic technology to create new products in the pharmaceutical, agricultural and nutrition businesses. Already, teh companies have over 20 products on the drawing board, said American CEO John Stafford, who with Monsanto CEO Robert Shapiro will be co-CEO of the new company. The companies hope to realize annual cost savings of $1.5 billion from the merger.

Comment:

Its proposed $34.5 bil merger with American Home Products creates a powerhouse in the life sciences industry

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Monsanto Co., Wyeth

---

Drugmaker giants plan merger

Article Abstract:

Hoechst of Germany intends to purchase Rhone-Poulenc of France in a deal valued at $20 billion, a development that will create a leading supplier of both drugs and agro-chemical products in the world. News of the deal, which will create a company with a combined sales revenue of $12.9 billion annually, contributed to an increase in both of the firms' shares in the US stock market. A union of Hoechst, the maker of the allergy drug, Allegra, and Rhone-Poulenc, the world's top vaccine company, is seen as an interesting development for the industry.

Comment:

Intends to purchase Rhone-Poulenc of France in a deal valued at $20 bil

Germany, France, Rhone-Poulenc S.A., Hoechst AG

Similar abstracts:

• Abstracts: Drug merger turns into tense triangle. Drug firms polish merger. $80 billion drug merger talks back on
• Abstracts: Bigger home loans please buyers, scare experts. U.S. mortgage rates duck below 7%. New wealth brings surge in two-home families
• Abstracts: Taking video games seriously, as art and product. Dance with aliens and save the world. Lose the seat belts and step on the gas
• Abstracts: Sawmill illustrates the buzz about productivity. Worker output spurts, helps control inflation. Computers complicate productivity
• Abstracts: Digital phone service routs analog. AT&T makes Net portable, free. AT&T launches biggest IPO today

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.